Overview | Medtronic

Creating Long-Term Shareholder Value

Medtronic is uniquely positioned to create long-term value in healthcare. The combination of Medtronic and Covidien creates a robust, market-leading medical technology and services company with a comprehensive product portfolio, broad geographic reach, and diversified growth profile. We believe Covidien meaningfully complements and accelerates our three primary strategies - therapy innovation, globalization, and economic value. We are focused on delivering a strong launch cadence of leading healthcare innovation, addressing the inequity in healthcare access globally, and becoming a leader in the changing value-based healthcare landscape with offerings that deliver both clinical and economic value to a broader set of partners around the world, including physicians, hospital systems, payers, governments, and patients. The addition of Covidien is expected to not only strengthen our long-term market competitiveness, but also increase our financial strength and capital deployment flexibility, driving further sustainability and consistency in our long-term performance. We believe that execution and reliable performance, combined with our disciplined allocation of capital, will create long-term value for our shareholders.

Latest Investor Information

June 10, 2015
Medtronic plc at the Goldman Sachs 36th Annual Global Healthcare Conference
June 02, 2015
Q4 2015 Medtronic plc Earnings Conference Call

Latest Press Releases

July 02, 2015Data Demonstrates Durability of Medtronic's VenaSeal Closure System, a Non-Tumescent, Non-Thermal and Non-Sclerosant Procedure for Chronic Venous Insufficiency
June 30, 2015Medtronic Announces Date for 2015 Annual Meeting
June 29, 2015American Heart Association's New Stroke Treatment Guidelines Establish Stent Retrievers as First-Line Endovascular Treatment for Acute Ischemic Stroke
June 25, 2015Medtronic Announces Expansion of MR-Conditional Products with U.S. Launch of Advisa SR MRI(TM) SureScan® Pacing System
Read More
img.alt

Sustainability Index Endorsements

Read more about our Sustainability efforts.

READ MORE
 
img.alt

Medtronic Spotlight

CNBC’s Meg Tirrell sits down with Medtronic CEO from the Piper Heartland Conference. (Hosted on CNBC.com)

Play Video
 
img.alt

Focus on Patients

The personal connection between Medtronic plc, its employees and patients.

Play Video
 
img.alt

History of Medtronic

A video history of the company.

Play Video

Investor Contacts

Stock Transfer Agent

Wells Fargo Shareowner Services
+1 888-648-8154

Medtronic Investor Relations Department

investor.relations@medtronic.com

+1 763-505-2692

Jeff Warren

Vice President, Investor Relations

Ryan Weispfenning

Senior Director, Investor Relations

View All
X